Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    - The page revision label was updated from v3.5.2 to v3.5.3, indicating a maintenance or template update. The change does not modify the displayed study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-30T18:53:40.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible changes to the study details on the page.
    Difference
    0.0%
    Check dated 2026-04-16T11:11:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added the NEJM 2015 paper by Larkin et al. on Combined Nivolumab and Ipilimumab for untreated melanoma; removed the Erratum entry for that publication.
    Difference
    0.0%
    Check dated 2026-04-02T04:56:33.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T19:34:16.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T17:56:12.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Publications section updated: two new articles added and one article removed.
    Difference
    0.1%
    Check dated 2026-03-04T15:09:05.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.